ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $114,004 | +5.0% | 32,250 | -4.6% | 0.00% | – |
| Q1 2024 | $108,549 | -37.9% | 33,816 | -5.4% | 0.00% | – |
| Q4 2023 | $174,788 | -13.1% | 35,744 | -3.5% | 0.00% | – |
| Q3 2023 | $201,122 | +18.2% | 37,039 | +46.9% | 0.00% | – |
| Q2 2023 | $170,170 | -59.6% | 25,222 | -47.3% | 0.00% | -100.0% |
| Q1 2023 | $420,936 | +19.1% | 47,827 | +0.5% | 0.00% | – |
| Q4 2022 | $353,299 | -3.5% | 47,587 | -5.0% | 0.00% | -100.0% |
| Q3 2022 | $366,000 | +2.2% | 50,097 | +10.7% | 0.00% | – |
| Q2 2022 | $358,000 | -12.9% | 45,275 | +54.2% | 0.00% | – |
| Q1 2022 | $411,000 | -18.0% | 29,356 | +138.9% | 0.00% | -100.0% |
| Q2 2021 | $501,000 | +128.8% | 12,290 | +126.3% | 0.00% | – |
| Q1 2021 | $219,000 | -42.2% | 5,430 | -15.4% | 0.00% | -100.0% |
| Q4 2020 | $379,000 | -2.3% | 6,415 | -20.0% | 0.00% | 0.0% |
| Q3 2020 | $388,000 | – | 8,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Matrix Capital Management Company, LP | 17,332,191 | $535,565,000 | 13.21% |
| TIGER MANAGEMENT L.L.C. | 1,115,411 | $34,466,000 | 13.06% |
| VIKING GLOBAL INVESTORS LP | 38,406,607 | $1,186,764,000 | 6.18% |
| Senator Investment Group LP | 5,113,085 | $146,145,000 | 3.67% |
| Casdin Capital, LLC | 463,125 | $14,310,562,000 | 1.48% |
| Graticule Asia Macro Advisors LLC | 356,326 | $11,010,000 | 0.86% |
| Ratan Capital Management LP | 41,272 | $1,275,000 | 0.67% |
| Rock Springs Capital Management LP | 545,000 | $16,841,000 | 0.67% |
| MYDA Advisors LLC | 34,000 | $1,051,000 | 0.48% |
| Aristotle Atlantic Partners, LLC | 50,459 | $1,559,000 | 0.45% |